Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Alberto Cózar, Antonio Ramos-Martínez, Esperanza Merino, Cristina Martínez -García, Evelyn Shaw, Teresa Marrodán, Esther Calbo, Elena Bereciartúa, Luis A. Sánchez- Muñoz, Miguel Salavert, M. Teresa Pérez-Rodríguez, Dácil García, J. María Bravo-Ferrer, Juan Gálvez-Acebal, César Henríquez, Jordi Cuquet, Helena Gil-Campesino, Luis Torres, Antonio Sánchez-Porto, Ana Royuela, Javier Cobo, José Romero, Alfonso Muriel, Livia Giner, Ferrere Federico, Martínez-Ruiz S. Rocío, Purificación Martos, Cristina Sardiña, Aguirre Elena, Cristina Badía, Alfonso Perales, Pedro A. De Santos-Castro, AngelBratos-Pérez Miguel, Sandra Cuellar, Gonzalez Eva, Pedro llinares, Castelo Laura, Isabel Morales, Alberto Delgado-Iribarren & Pilar Mairal. (2019) High delayed mortality after the first episode of Clostridium difficile infection. Anaerobe 57, pages 93-98.
Crossref
Crossref
Claire Goodman, Christine Norton, Marina Buswell, Bridget Russell, Danielle Harari, Rowan Harwood, Brenda Roe, Jo Rycroft-Malone, Vari M Drennan, Mandy Fader, Michelle Maden, Karen Cummings & Frances Bunn. (2017) Managing Faecal INcontinence in people with advanced dementia resident in Care Homes (FINCH) study: a realist synthesis of the evidence. Health Technology Assessment 21:42, pages 1-220.
Crossref
Crossref
Klaus Nissle, Daniel Kopf & Alexander Rösler. (2016) Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients. BMC Geriatrics 16:1.
Crossref
Crossref
Jorge Silva-VelazcoTracy L. HullCraig Messick & James M. Church. (2016) Medical versus Surgical Patients with Clostridium difficile Infection: Is There Any Difference?. The American Surgeon 82:12, pages 1155-1159.
Crossref
Crossref
Sachin VaidJohn Sung Park & Robert John Sinnott. (2016) Outcomes of Recurrent Rectal Cancer after Transanal Excision. The American Surgeon 82:2, pages 152-155.
Crossref
Crossref
Rowena Almeida, Teklu Gerbaba & Elaine O. Petrof. (2015) Recurrent Clostridium difficile infection and the microbiome. Journal of Gastroenterology 51:1, pages 1-10.
Crossref
Crossref
Iyad Issa & Rami Moucari. (2014) Probiotics for antibiotic-associated diarrhea: Do we have a verdict?. World Journal of Gastroenterology 20:47, pages 17788-17795.
Crossref
Crossref
R. Shivashankar, S. Khanna, P. P. Kammer, W. Scott Harmsen, A. R. Zinsmeister, L. M. Baddour & D. S. Pardi. (2014)
Clinical predictors of recurrent
Clostridium difficile
infection in out-patients
. Alimentary Pharmacology & Therapeutics, pages n/a-n/a.
Crossref
Crossref
Daniel E Freedberg, Hojjat Salmasian, Carol Friedman & Julian A Abrams. (2013) Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients. American Journal of Gastroenterology 108:11, pages 1794-1801.
Crossref
Crossref
Surabhi K. Taori, Allison Wroe & Ian R. Poxton. (2013) Clostridium difficile infections in South East Scotland: mortality and recurrence in a region without PCR ribotype 027. Journal of Medical Microbiology 62:9, pages 1468-1477.
Crossref
Crossref
Timothy A. Rubin, Charles E. Gessert, Johannes Aas & Johan S. Bakken. (2013) Fecal microbiome transplantation for recurrent Clostridium difficile infection: Report on a case series. Anaerobe 19, pages 22-26.
Crossref
Crossref
Yong Gil Kim, David Y. Graham & Byung Ik Jang. (2012) Proton Pump Inhibitor Use and Recurrent Clostridium difficile-associated Disease. Journal of Clinical Gastroenterology 46:5, pages 397-400.
Crossref
Crossref
Hee Kyoung ChoiKye Hyung KimSun Hee LeeSu Jin Lee. (2011)
Risk Factors for Recurrence of
Clostridium difficile
Infection: Effect of Vancomycin-resistant Enterococci Colonization
. Journal of Korean Medical Science 26:7, pages 859.
Crossref
Crossref
Lynne V McFarland & Christina M Surawicz. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
335
354
.
Jose Cadena, George R. ThompsonIIIIII, Jan E. Patterson, Kelly Echevarria, Brandy Nakashima, Eric M. Mortensen & Aaron Owens. (2010) Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection. The American Journal of the Medical Sciences 339:4, pages 350-355.
Crossref
Crossref
M.P. Bauer, E.J. Kuijper & J.T. van Dissel. (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clinical Microbiology and Infection 15:12, pages 1067-1079.
Crossref
Crossref
Lawrence R. Schiller. (2009) Diarrhea and Malabsorption in the Elderly. Gastroenterology Clinics of North America 38:3, pages 481-502.
Crossref
Crossref
Danielle Harari. (2009) Faecal incontinence in older people. Reviews in Clinical Gerontology 19:2, pages 87-101.
Crossref
Crossref
N. Salles. (2009) Clostridium difficile: prévalence, conséquences et traitement chez la personne âgéeClostridium difficile: prevalence, consequences and treatment in elderly patients. Les cahiers de l'année gérontologique 1:1, pages 73-79.
Crossref
Crossref
Thomas A. Brown, Timothy R. Pasquale, John C. Fondran, Hector H. Bonilla, Michael J. Cullado, Frederick A. Slezak & Joseph P. Myers. (2009) Clostridium difficile-Associated Proctitis of the Rectal Stump. Infectious Diseases in Clinical Practice 17:1, pages 71-74.
Crossref
Crossref
Haihui Huang & Carl Erik Nord. (2008) Can metronidazole still be used for treatment of Clostridium difficile infections?. Current Infectious Disease Reports 11:1, pages 3-6.
Crossref
Crossref
Xavier Hébuterne, Emmanuel Alix, Agathe Raynaud-Simon & Bruno VellasX. Hébuterne. 2009. Traité de nutrition de la personne âgée. Traité de nutrition de la personne âgée
89
93
.
K.W. Garey, S. Sethi, Y. Yadav & H.L. DuPont. (2008) Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. Journal of Hospital Infection 70:4, pages 298-304.
Crossref
Crossref
R.-P. Vonberg, E.J. Kuijper, M.H. Wilcox, F. Barbut, P. Tüll, P. Gastmeier, P.J. van den Broek, A. Colville, B. Coignard, T. Daha, S. Debast, B.I. Duerden, S. van den Hof, T. van der Kooi, H.J.H. Maarleveld, E. Nagy, D.W. Notermans, J. O'Driscoll, B. Patel, S. Stone & C. Wiuff. (2008) Infection control measures to limit the spread of Clostridium difficile. Clinical Microbiology and Infection 14, pages 2-20.
Crossref
Crossref
Efi Kokkotou, Alan C. Moss, Athanasios Michos, Daniel Espinoza, Jeffrey W. Cloud, Nasima Mustafa, Michael O'Brien, Charalabos Pothoulakis & Ciarán P. Kelly. (2008)
Comparative Efficacies of Rifaximin and Vancomycin for Treatment of
Clostridium difficile
-Associated Diarrhea and Prevention of Disease Recurrence in Hamsters
. Antimicrobial Agents and Chemotherapy 52:3, pages 1121-1126.
Crossref
Crossref
Kianoosh Katchar, Claribel P. Taylor, Sanjeev Tummala, Xinhua Chen, Javed Sheikh & Ciarán P. Kelly. (2007) Association Between IgG2 and IgG3 Subclass Responses to Toxin A and Recurrent Clostridium difficile–Associated Disease. Clinical Gastroenterology and Hepatology 5:6, pages 707-713.
Crossref
Crossref
J. Pepin, S. Routhier, S. Gagnon & I. Brazeau. (2006) Management and Outcomes of a First Recurrence of Clostridium difficile-Associated Disease in Quebec, Canada. Clinical Infectious Diseases 42:6, pages 758-764.
Crossref
Crossref
Lynne V McFarland & Christina M Surawicz. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
285
301
.
Christina M Surawicz. (2004) Treatment of recurrent Clostridium difficile-associated disease. Nature Clinical Practice Gastroenterology & Hepatology 1:1, pages 32-38.
Crossref
Crossref
Xavier Hébuterne. (2003) Gut changes attributed to ageing: effects on intestinal microflora. Current Opinion in Clinical Nutrition and Metabolic Care 6:1, pages 49-54.
Crossref
Crossref